Clinical trials: Cardiovascular Risk Factor
Cardiovascular Risk Factor
Prospective, Single-Center, Non-Randomized Study of the PhysioWave™ Cardiovascular Analyzer
This is a prospective, single-center, non-randomized validation study being conducted under a non-significant risk study design with the primary aim to evaluate PWV, PR, and BW accuracy in a sample of subjects representative of…
- Trial name
- NCT03126994
- Testing
- PhysioWave Cardiovascular Analyzer, AtCor XCEL PWA & PWV, Detecto SOLO
- Where
- United States
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- PhysioWave, Inc.
Cardiovascular Risk Factor
Correlation Between the SPhENo-Cardiograph™, a Seismocardiograph Device, and GE Vivid Q, an Echocardiograph, for Known Systemic Timing Intervals (STI)
The study Sponsor, Heart Force Medical Inc. (HFM), has developed a patented medical device called the SPhENo-CardiographTM. The SPhENo-Cardiograph™ provides a non-invasive assessment of the electro-mechanical function of the…
- Trial name
- NCT02636023
- Testing
- SPhENo-Cardiograph
- Where
- Canada
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Heart Force Medical Inc.
Cardiovascular Risk Factors, Cardiovascular Diseases
Management of Cardiovascular Risk Factors
This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases.
- Trial name
- NCT00848380
- Where
- 36 sites in Switzerland
- Volunteers
- 1,492 people, healthy volunteers welcome
- Sponsor
- AstraZeneca
Cardiovascular Risk Factors, Hyperlipidemia
European Study of Cardiovascular Risk
The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries.
- Conditions
- Cardiovascular Risk Factors, Hyperlipidemia, Hypertension, Diabetes
- Trial name
- EURIKA (NCT00882336)
- Where
- 775 sites in Austria, Belgium and 10 more
- Volunteers
- 7,200 people
- Sponsor
- AstraZeneca
Cardiovascular Risk Factors
Study on Effects of a Dairy Product Based on Polyphenols and Enriched With Vitamins B6, B9 and B12 on Some Cardiovascular Factor of Risk
We put forward that polyphenols and vitamins have a cardiovascular prevention effect for subject with cardiovascular risk.
- Trial name
- NCT00706888
- Testing
- Vitamins B6, B9 and B12 and polyphenols
- Where
- France
- Volunteers
- 64 people
- Sponsor
- Elvir SAS